WallStSmart

WeRide Inc. American Depositary Shares (WRD)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

WeRide Inc. American Depositary Shares generates 164% more annual revenue ($684.59M vs $258.90M). ZEPP leads profitability with a -15.5% profit margin vs -241.7%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

WRD

Hold

35

out of 100

Grade: F

Growth: 6.7Profit: 2.0Value: 6.0Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

WRDUndervalued (+24.5%)

Margin of Safety

+24.5%

Fair Value

$10.00

Current Price

$7.48

$2.52 discount

UndervaluedFair: $10.00Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

WRD2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
123.0%10/10

Revenue surging 123.0% year-over-year

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

WRD4 concerns · Avg: 2.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-22.1%2/10

ROE of -22.1% — below average capital efficiency

Profit MarginProfitability
-241.7%1/10

Currently unprofitable

Operating MarginProfitability
-182.7%1/10

Operating margin of -182.7%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : WRD

The strongest argument for WRD centers on Revenue Growth, Price/Book. Revenue growth of 123.0% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : WRD

The primary concerns for WRD are EPS Growth, Return on Equity, Profit Margin.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

WRD is growing revenue faster at 123.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 35/100) and 43.0% revenue growth. WRD offers better value entry with a 24.5% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

WeRide Inc. American Depositary Shares

TECHNOLOGY · SOFTWARE - APPLICATION · USA

WeRide, Inc. is a China-based company founded in 2017 and headquartered in Guangzhou. It focuses on developing and selling autonomous vehicles—such as robotaxis, robobuses, and robosweepers—along with related sensor technologies.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?